A new model incorporating clinical variables with bile acids could be a predictor of the risk of developing recurrent Clostridioides difficile infections (CDI).
In data presented during the 2021 Digestive Disease Week (DDW) Virtual Meeting, a team, led by Jessica R. Allegretti, Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital, investigated novel biomarkers as potential predictors for C difficile recurrence.
